Skip to main content
Medical information Clinical review pending

Infection Testing

SARS-CoV-2 Antibodies Profile Test

Assess your immune response to COVID-19 with the SARS-CoV-2 Antibodies Profile Test. This test checks for IgG and total antibodies, indicating past infection or vaccination.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (1 mL minimum) serum collected in an SST tube.
Results
Reports are typically available the next day if the sample is received by 11 am. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 2,925

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the SARS-CoV-2 Antibodies Profile Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a history of COVID-19 symptoms.
  • ✓Individuals with known exposure to SARS-CoV-2.
  • ✓Individuals seeking to understand their immune response post-vaccination.
  • ✓Population surveillance studies.
  • ✓Assessing potential immunity levels.
02

In plain language

What this test helps you understand

This test helps determine if an individual has developed antibodies against SARS-CoV-2, potentially indicating past infection or response to vaccination. It aids in understanding immune status related to COVID-19.
The SARS-CoV-2 Antibodies Profile Test is a diagnostic tool used to detect antibodies against the SARS-CoV-2 virus, which causes COVID-19. This test helps understand your body's immune response to the virus.

This test measures two types of antibodies:

* **SARS-CoV-2 Antibody, IgG:** Detects antibodies that typically develop after a past infection or vaccination, indicating an immune response. * **SARS-CoV-2 Antibody, Total:** Measures the overall level of antibodies (including IgG and IgM) against the virus, providing a broader view of the immune response.

This test can be useful for individuals who have had COVID-19 symptoms, have been exposed to the virus, or want to understand their immune status after vaccination. It helps determine if you have developed antibodies, which may suggest some level of immunity. However, a positive result does not guarantee complete protection against future infections. Always discuss your results with a healthcare provider for proper interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for this test. Confirm with the laboratory before booking.
Sample3 mL (1 mL minimum) serum collected in an SST tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects antibodies, which may take time to develop after infection or vaccination. A negative result does not rule out current or recent infection. The presence of antibodies does not guarantee complete immunity or protection against future infection. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test checks for antibodies (IgG and Total) against the SARS-CoV-2 virus, indicating if your body has mounted an immune response, potentially due to past infection or vaccination.
No, this test looks for antibodies, which are signs of a past response. It is not used to diagnose an active infection. Tests like PCR or antigen tests are used for current infection diagnosis.
A positive result suggests you have developed antibodies, which may offer some protection. However, the level and duration of immunity are still being studied. It does not guarantee complete protection against reinfection.
No specific fasting is required for this test. Confirm with the laboratory before booking.
The sample is collected via a blood draw, requiring approximately 3 mL of serum.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp